Hematologic Disorder: Clinical Trials

1 trial for Hematologic Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Hematologic Disorder: new trials by email Literature Review of Hematologic Disorder trials Research Report on Hematologic Disorder

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
Lenalidomide, Influenza Vaccine, Pneumovax Vaccine - Hematologic Disorder
Phase 2TerminatedM.D. Anderson Cancer Center32014-11-242018-09-20

Narrower conditions

Agammaglobulinemia (1)  ·  Hematologic Diseases (1)  ·  Influenza, Human (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)

Broader conditions

Blood Protein Disorders (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Leukemia (1)  ·  Leukemia, B-Cell (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Influenza Vaccines (1)  ·  Lenalidomide (1)  ·  SARS-CoV-2 inactivated vaccines (1)

Sponsors

M.D. Anderson Cancer Center (1)

Countries

United States (1)

Top investigators

Alessandra Ferrajoli, MD,BS (1)